[go: up one dir, main page]

DE60038610D1 - Neue kristalline formen eines macrolidantibiotikums - Google Patents

Neue kristalline formen eines macrolidantibiotikums

Info

Publication number
DE60038610D1
DE60038610D1 DE60038610T DE60038610T DE60038610D1 DE 60038610 D1 DE60038610 D1 DE 60038610D1 DE 60038610 T DE60038610 T DE 60038610T DE 60038610 T DE60038610 T DE 60038610T DE 60038610 D1 DE60038610 D1 DE 60038610D1
Authority
DE
Germany
Prior art keywords
macrolidantibiotic
new crystalline
crystalline shapes
shapes
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60038610T
Other languages
English (en)
Other versions
DE60038610T2 (de
Inventor
Robert John Rafka
Douglas John Allen
Colman Brendan Ragan
Barry James Morton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Application granted granted Critical
Publication of DE60038610D1 publication Critical patent/DE60038610D1/de
Publication of DE60038610T2 publication Critical patent/DE60038610T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60038610T 1999-05-18 2000-04-14 Neue kristalline formen eines makrolidantibiotikums Expired - Lifetime DE60038610T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13464499P 1999-05-18 1999-05-18
US134644P 1999-05-18
PCT/IB2000/000463 WO2000069874A1 (en) 1999-05-18 2000-04-14 Novel crystalline forms of a macrolide antibiotic

Publications (2)

Publication Number Publication Date
DE60038610D1 true DE60038610D1 (de) 2008-05-29
DE60038610T2 DE60038610T2 (de) 2009-06-25

Family

ID=22464300

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60038610T Expired - Lifetime DE60038610T2 (de) 1999-05-18 2000-04-14 Neue kristalline formen eines makrolidantibiotikums

Country Status (43)

Country Link
US (1) US6583274B1 (de)
EP (1) EP1189912B1 (de)
JP (1) JP3897983B2 (de)
KR (1) KR100474229B1 (de)
CN (1) CN1203084C (de)
AP (1) AP2001002325A0 (de)
AR (1) AR020030A1 (de)
AT (1) ATE392427T1 (de)
AU (1) AU772283B2 (de)
BG (1) BG106150A (de)
BR (1) BR0011300A (de)
CA (1) CA2372206C (de)
CZ (1) CZ20014120A3 (de)
DE (1) DE60038610T2 (de)
DK (1) DK1189912T3 (de)
DZ (1) DZ3043A1 (de)
EA (1) EA003417B1 (de)
ES (1) ES2302689T3 (de)
GT (1) GT200000072A (de)
HK (1) HK1045521B (de)
HN (1) HN2000000056A (de)
HR (1) HRP20010849A2 (de)
HU (1) HUP0201341A3 (de)
IL (2) IL145946A0 (de)
IS (1) IS6127A (de)
MA (1) MA26735A1 (de)
MX (1) MXPA01011914A (de)
MY (1) MY133397A (de)
NO (1) NO320195B1 (de)
NZ (1) NZ514765A (de)
OA (1) OA11876A (de)
PA (1) PA8495001A1 (de)
PE (1) PE20010151A1 (de)
PL (1) PL353316A1 (de)
PT (1) PT1189912E (de)
SK (1) SK16472001A3 (de)
TN (1) TNSN00103A1 (de)
TW (1) TWI225066B (de)
UA (1) UA67842C2 (de)
UY (1) UY26144A1 (de)
WO (1) WO2000069874A1 (de)
YU (1) YU76601A (de)
ZA (1) ZA200109420B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
DE60003586T2 (de) 2000-01-27 2004-01-08 Pfizer Products Inc., Groton Antibiotische azalid-zusammensetzungen
EP1383780A1 (de) * 2001-04-27 2004-01-28 Pfizer Products Inc. Verfahren zur herstellung von 4"-substituierte-9-deoxo-9a-homoerythromycin a derivate
EP1435359A1 (de) * 2002-12-31 2004-07-07 Alembic Limited Verfahren zur Reinigung von Roxithromycin
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
CA2748847A1 (en) * 2009-01-30 2010-08-05 Glaxo Group Limited Anti-inflammatory macrolide
EP2402355A1 (de) * 2010-07-01 2012-01-04 Novartis AG Kristalline wasserfreie Formen II und III von Tulathromycin
EP2736915A1 (de) 2011-07-27 2014-06-04 Farma GRS, d.o.o. Neue kristalline formen von tulathromycin
CN106008622A (zh) * 2016-08-02 2016-10-12 海门慧聚药业有限公司 泰拉霉素新晶型及其制备
CN109942652B (zh) * 2017-12-21 2022-04-26 洛阳惠中兽药有限公司 一种莱柯霉素晶型ⅰ及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO107257B1 (ro) * 1987-07-09 1993-10-30 Pfizer Procedeu de obtinere a unui dihidrat de azitromicina, cristalin
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
US5844105A (en) * 1996-07-29 1998-12-01 Abbott Laboratories Preparation of crystal form II of clarithromycin
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.

Also Published As

Publication number Publication date
BG106150A (bg) 2002-05-31
PE20010151A1 (es) 2001-02-08
CN1351607A (zh) 2002-05-29
SK16472001A3 (sk) 2003-02-04
WO2000069874A1 (en) 2000-11-23
ES2302689T3 (es) 2008-08-01
EP1189912A1 (de) 2002-03-27
AP2001002325A0 (en) 2001-12-31
HUP0201341A3 (en) 2003-03-28
US6583274B1 (en) 2003-06-24
CA2372206C (en) 2006-01-10
HUP0201341A2 (en) 2002-08-28
NZ514765A (en) 2004-05-28
DE60038610T2 (de) 2009-06-25
IL145946A (en) 2007-06-17
TNSN00103A1 (fr) 2005-11-10
DK1189912T3 (da) 2008-06-30
UY26144A1 (es) 2000-12-29
TWI225066B (en) 2004-12-11
JP3897983B2 (ja) 2007-03-28
PT1189912E (pt) 2008-05-16
MXPA01011914A (es) 2002-05-06
MY133397A (en) 2007-11-30
JP2002544283A (ja) 2002-12-24
PA8495001A1 (es) 2002-02-21
HN2000000056A (es) 2001-02-02
NO320195B1 (no) 2005-11-14
UA67842C2 (uk) 2004-07-15
EA003417B1 (ru) 2003-04-24
CN1203084C (zh) 2005-05-25
YU76601A (sh) 2004-09-03
OA11876A (en) 2006-03-27
CZ20014120A3 (cs) 2003-01-15
PL353316A1 (en) 2003-11-17
EA200100984A1 (ru) 2002-06-27
NO20015598L (no) 2002-01-08
AU772283B2 (en) 2004-04-22
IL145946A0 (en) 2002-07-25
AU3572900A (en) 2000-12-05
DZ3043A1 (fr) 2004-03-27
KR20020007415A (ko) 2002-01-26
AR020030A1 (es) 2002-03-27
GT200000072A (es) 2001-11-08
IS6127A (is) 2001-10-26
ZA200109420B (en) 2002-11-15
KR100474229B1 (ko) 2005-03-08
HRP20010849A2 (en) 2003-04-30
ATE392427T1 (de) 2008-05-15
HK1045521B (zh) 2005-12-09
BR0011300A (pt) 2002-02-26
MA26735A1 (fr) 2004-12-20
CA2372206A1 (en) 2000-11-23
NO20015598D0 (no) 2001-11-16
HK1045521A1 (en) 2002-11-29
EP1189912B1 (de) 2008-04-16

Similar Documents

Publication Publication Date Title
ATE337334T1 (de) Phosphonatderivate eines glykopeptides
DE60129334D1 (en) Polymorphe formen eines epothilon-analogons
ATE271031T1 (de) Neue phenylpropargyletherderivate
DE60124952D1 (de) Ausnehmungsprofil eines suszeptors zum verbessern des prozesses
ATE282043T1 (de) Neue aminopropylphosphinsäuren
ATE211604T1 (de) Aufhängung eines reihenräumers
ID26441A (id) Proses untuk memproduksi ftalat anhidrida
DE60041208D1 (de) Stellung eines Hebezeuges
DE69834007D1 (de) Endpol eines Drehmelders
DE60122181D1 (de) Regelung eines turboladers
DE60038610D1 (de) Neue kristalline formen eines macrolidantibiotikums
DE69932920D1 (de) Neue dihydroxyhexansäurederivate
DE50212842D1 (de) Vermeidung des rückrollens eines fahrzeuges
ATA2512000A (de) Deformationselement eines schienenfahrzeuges
ATE265422T1 (de) Neue phenylheteroalkylamin-derivate
DE60019461D1 (de) Neue polymorphe formen von olanzapin
DE69926723D1 (de) Gestell eines Druckers
DE60126125D1 (de) Neue carbapenem-derivate
DE50009162D1 (de) Rotormast eines hubschraubers
ID27701A (id) Proses untuk membuat senyawa-senyawa kroman yang diesterifikasi
DE60121607D1 (de) Gerät zur protokollübersetzung mit hilfe eines generischen zwischenprotokolls
DE69915044D1 (de) Verriegelbare Betätigungseinheit eines Ventils
DE50207478D1 (de) Pedalarm eines Fahrrades
DE60021956D1 (de) Herstellung einer Gasflasche
FI990641A0 (fi) Menetelmä kaupankäynnin tehostamiseen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition